Wadsworth, IL, United States of America

Imran Ahmad

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 164(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1997 - 2001)
  • Cranbury, NJ (US) (1998 - 2003)
  • Wadsworth, IL (US) (2006 - 2017)
  • Libertyville, IL (US) (2016 - 2023)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Innovations of Imran Ahmad: Pioneering Treatments for Psychiatric and Neurodegenerative Diseases

Introduction

Imran Ahmad, based in Wadsworth, IL, is a prolific inventor with an impressive portfolio of 31 patents. His work focuses on developing innovative treatments for various psychiatric and neurodegenerative diseases. Through his research and formulations, he is making significant contributions to the fields of medicine and pharmacology.

Latest Patents

Among Imran Ahmad's latest patents is the development of endoxifen methods and compositions for the inhibition of protein kinase C. This invention provides compositions containing endoxifen, which have been formulated for the treatment of subjects with psychiatric conditions such as bipolar disorder, schizophrenia, and various neurodegenerative diseases including Alzheimer’s and Parkinson’s diseases. Additionally, he has invented methods for preparing stable compositions containing thymoquinone, which include combinations with phosphatidylcholine and guggulsterol derivatives. These stable preparations can be administered in various forms, including tablets and ointments, enhancing patient accessibility to innovative treatments.

Career Highlights

Imran Ahmad has played a key role in advancing pharmaceutical science through his innovative work. He has been associated with prominent companies like The Liposome Company, Inc. and Jina Pharmaceuticals, Inc., where he has contributed his expertise to develop new therapeutic solutions. His continued focus on invention and improvement in drug formulations showcases his commitment to addressing acute medical needs.

Collaborations

Throughout his career, Imran has collaborated with notable professionals such as Andrew S. Janoff and Eric G. Mayhew. These partnerships have enriched his research, aiding in the exploration of new avenues in drug development and enhancing the effectiveness of therapeutic agents in clinical applications.

Conclusion

Imran Ahmad’s dedication to innovation in the pharmaceutical industry is evident through his substantial number of patents and the impact of his inventions. His work on treatments for psychiatric and neurodegenerative diseases holds promise for improving the lives of many individuals affected by these conditions. With his continued research and collaborations, Imran Ahmad is set to remain a significant figure in the evolution of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…